cyclopentane has been researched along with Cancer of Nasopharynx in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, L; Cao, Y; Huang, BJ; Jia, LJ; Luo, DH; Mei, Y; Meng, DF; Peng, LX; Qian, CN; Qiang, YY; Sun, R; Wang, MY; Xiang, YQ; Xie, P; Yang, JP; Yun, JP; Zheng, LS | 1 |
1 other study(ies) available for cyclopentane and Cancer of Nasopharynx
| Article | Year |
|---|---|
Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target.
Topics: Adult; Animals; Antineoplastic Agents; Apoptosis; Carcinogenesis; Carcinoma; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclopentanes; Female; Gamma Rays; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; Lymphatic Metastasis; Male; Mice; Mice, Nude; Middle Aged; Molecular Targeted Therapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; NEDD8 Protein; Neoplastic Stem Cells; Pyrimidines; RNA, Small Interfering; Signal Transduction; Survival Analysis; Xenograft Model Antitumor Assays | 2017 |